Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
暂无分享,去创建一个
M. Rudnick | B. Freedman | T. Steinman | D. Roth | J. Sloand | G. Schulman | W. Williams | R. Smith | C. Shadur | F. Hatch | Michael R. Rudnick | Dennis A. Revicki | David Roth | Theodore I. Steinman | Gerald Schulman | Ronald D. Smith | Fred E. Hatch | James A. Sloand | Barry I. Freedman | Winfred W. Williams | Craig A. Shadur | Robert L. Benz | Brendan P. Teehan | Brenda J. Sarokhan | Robert I. Abels | B. P. Teehan | Winfred Williams
[1] J. Park,et al. Effect of recombinant human erythropoietin on muscle energy metabolism in patients with end-stage renal disease: a 31P-nuclear magnetic resonance spectroscopic study. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] B. Brenner,et al. Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension. , 1991, Journal of the American Society of Nephrology : JASN.
[3] J. Spivak,et al. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. , 1990, The American journal of medicine.
[4] A. Levey,et al. Measurement of renal function in chronic renal disease. , 1990, Kidney international.
[5] R. Asinger,et al. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. , 1990, American journal of nephrology.
[6] R. Degowin,et al. Effect of recombinant human erythropoietin on renal function in humans. , 1990, Kidney international.
[7] R. Abels,et al. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] R. Degowin,et al. The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] J. Adamson,et al. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.
[10] B. Kahan. The impact of cyclosporine on the practice of renal transplantation. , 1989, Transplantation proceedings.
[11] R. Degowin,et al. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. , 1989, Annals of internal medicine.
[12] D. Peterson,et al. Hematologic and physiologic studies during correction of anemia with recombinant human erythropoietin in predialysis patients , 1989 .
[13] R. Verberckmoes,et al. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] T. Pincus,et al. Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo‐Controlled Trial , 1988, The American journal of the medical sciences.
[15] B. Brenner,et al. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[16] N. Gretz,et al. Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats. , 1988, Contributions to nephrology.
[17] D. Harris,et al. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. , 1986, Kidney international.
[18] B. Brenner. Nephron adaptation to renal injury or ablation. , 1985, The American journal of physiology.
[19] W. Mitch,et al. A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.
[20] W. Sluiter,et al. PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE , 1984, The Lancet.
[21] W. Mitch,et al. A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.
[22] B. Brenner,et al. Dynamics of Glomerular Ultrafiltration in the Rat: VIII. EFFECTS OF HEMATOCRIT , 1975, Circulation research.
[23] A. Hull,et al. Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. , 1973, Kidney international.
[24] M. Black. Letter: Cryostat sections in immunological studies of cancer. , 1973, Lancet.
[25] B. Brenner,et al. The dynamics of glomerular ultrafiltration in the rat. , 1971, The Journal of clinical investigation.
[26] D. M. Allen,et al. Analysis of growth and dose response curves. , 1969, Biometrics.